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The treatment of severe musculoskeletal injuries is currently limited to surgical
intervention and natural healing during recovery, which are not always sufficient to repair critical
defects. Various cell-based approaches for repair augmentation have gained traction, however
a reliable cell therapy approach has not been realized. Pluripotent stem cells (PSCs) retain the
developmental potential to become any cell in the human body and are a valuable model for
studying cell differentiation that hold tremendous promise for treating orthopedic injuries. The
goal of our research has been to develop an efficient in vitro differentiation method to generate
skeletal progenitor cells, the forerunners of osteoblasts, chondrocytes and tenocytes,
responsible for creation and maintenance bone, cartilage and tendon, respectively. We have
focused on generating paraxial mesoderm, a specific type of mesoderm whose derivatives give
rise to all cell types comprising the axial skeleton. Our approach progressively differentiates
PSCs to mimic their natural maturation during embryonic development in order to study the
mechanisms directing these events. We have genetically engineered mouse and human
embryonic stem cells (ESCs) to express fluorescent protein reporters that enable us to visualize
expression of critical genes during differentiation. This allows us to have a rapid diagnostic
readout on the effectiveness of experimental conditions and subsequently sort out individual
cells of interest for further analysis. The outcomes of my thesis work demonstrate that
activation of the Wnt pathway coupled with inverse agonism of retinoic acid receptor (RAR)

Ryan Patrick Russell – University of Connecticut, 2018
signaling is capable of inducing paraxial mesoderm, an intermediate cell type arising early in
development and a key phase in the progression from PSCs to skeletal progenitor cells. Our
studies reveal paraxial mesoderm induction is significantly more efficient from the “primed” or
epiblast stem cell state compared to the “naïve” inner cell mass like state. Further, inverse
agonism of RARs during the formation of epiblast-like cells favors a paraxial mesoderm fate.
Collectively, my thesis work has provided a more complete understanding of the molecular
mechanisms prompting stem cell specification into paraxial mesoderm, as well as an earlier
than appreciated role for RARs in epiblast cells where they potentially function as transcriptional
repressors.
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CHAPTER 1

INTRODUCTION
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INTRODUCTION

1.1 Stem Cells and Orthopaedic Regenerative Medicine
Regeneration of bone tissue lost due to injury or disease remains an unmet clinical
challenge1. Critical-size bone defects, known as non-unions, are predominantly treated
via autologous bone grafts, often harvested from the patient’s iliac crest. Limitations
inherent to the autograft approach, including increased risk of infection, poor integration,
chronic pain, donor site morbidity and limited tissue supply, have propelled the search for
alternative interventions. Use of synthetic bone substitutes and administration of
recombinant growth factors such as bone morphogenetic proteins (BMPs) have also been
explored but are also limited by high costs and adverse side effects. Various cell-based
approaches for repair augmentation have been gaining traction, notably bone marrowderived mesenchymal stem cells (MSCs)2. However, inconsistent outcomes and the
overall variability of this adult stem cell population has thus far curtailed the clinical impact
of MSCs on bone regeneration3. Therefore, reliable cell-based therapeutic options,
without the need for high doses of growth factors and potential off-target effects, will
continue to be explored. Embryonic stem cells (ESCs) and induced pluripotent stem cells
(iPSCs) provide a valuable model for studying cell maturation and lineage differentiation
due to their pluripotent nature and may soon be broadly used for treating orthopedic
injuries4,5.

The impact of stem cell technologies on recent advances in basic science
research and emerging regenerative medicine therapies has been tremendous, however
the prospect of fully harnessing the pluripotent and self-renewal capabilities of embryonic
or induced pluripotent stem cells may be as onerous as it is appealing. With over 200
distinct human cell types catalogued, preventing a stem cell from becoming any particular
2

cell type may be just as important, and as difficult, as generating the cell type of interest
from a given differentiation protocol. Likewise, dynamic processes such as establishment
of the morphogenetic gradients responsible for directing cell migration and lineage
specification in the developing embryo are not easily recapitulated in vitro6. Similar events
initiate the healing response within the tissue microenvironment surrounding a fracture
site by recruiting adult stem cells which then differentiate to replace damaged cells.
Consequently, understanding the mechanics of stem cell specification and differentiation
is paramount for developing cell-based regenerative medicine strategies. In terms of the
skeletal stem cell biology field, a more comprehensive understanding of how to direct
pluripotent stem cells (PSC)s into mature, functional skeletal cell types remains a
necessity and will be an essential advancement in the realm of orthopaedic translational
medicine.

We have focused on a differentiation strategy that is more reflective of early
embryonic development. This approach follows a stepwise, embryonic differentiation
program to derive cells of the axial skeletal lineage via paraxial mesoderm and sclerotome
intermediates to generate a functional and sustainable therapeutic cell source. Our
current focus is on optimizing the generation of cells characteristic of paraxial mesoderm
through a more precise control of embryonic signaling mechanisms in order to improve
subsequent differentiation into the somitic stage and eventual derivation of skeletal cell
progenitors

1.2 Stem Cells and Embryogenesis
Mammalian embryogenesis is initiated by the formation of a diploid, single-celled
zygote following egg fertilization. Several rounds of mitotic cell divisions via rotational
holoblastic cleavage create a dense sphere of cells called the morula7. The blastocyst
3

stage initiates as cells form a hollow sphere surrounding an inner fluid-filled cavity known
as the blastocoel. The first embryonic cell specification events occur at this stage as cell
of the outer layer begin to form the trophoblast, which will contribute to forming extraembryonic tissues, including the placenta8,9. Cells on the interior of the blastocyst gather
to form the inner cell mass which eventually gives rise to the definitive fetal structures.
This early delineation of cell fate was critical for mammalian evolution and is a defining
juncture for the origination of embryonic stem cell research. The characteristic abilities of
ESCs to proliferate continuously, maintain a stable karyotype, and differentiate into any
cell type result from their derivation from the inner cell mass at the pre-implantation
blastocyst stage. Significant advances in culturing techniques developed on mouse ESCs
led to the eventual generation of human ESC lines, only two decades prior to this text10,11.
The blastocysts used for derivation of these lines were produced for clinical conception
purposes via in vitro fertilization.

1.3 Stem Cell States
It is a fundamental, yet important distinction that not all stem cells are the same,
especially when considering the multitude of stem cell lines derived and characterized
from mammalian sources other than mouse or human. Similarly, mouse and human
ESCs exist in alternative ‘states’, due to differences in the timing of embryonic
development between the two species12 (Fig. 1.1). Mouse ESCs are isolated from the
inner cell mass and are thus able to be maintained in a state of naïve pluripotency, which
refers to their ability to contribute to all adult tissues including the gametes11. Because of
the extended culture duration required between blastocyst isolation and emergence of
stable human ESCs in vitro, it is understood that they more closely resemble the
pluripotency state of post-implantation cells of the epiblast. The flat, cobble-stoned
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Figure 1.1. Comparison of pluripotent stem cells derived from mouse and human
embryos.

Differences in timing of in vivo mouse and human development and the

derivation of pluripotent cell lines in vitro. The extended culture duration required for
obtaining human embryonic stem cell outgrowth causes these cells to grow to the
equivalency of mouse EpiSCs, which are derived from the post-implantation embryo12.

appearance of human ESCs and the mound-like morphology of mouse ESCs are
characteristic of their respective pluripotency states (Fig 1.2).

The identification of defined culture conditions via inhibition of ERK signaling in
combination with inhibition of glycogen synthases kinase 3 (GSK3) using two small
molecule inhibitors, termed ‘2i’, vastly improved the derivation efficiency of naïve stem
cells by blocking differentiation cues normally promoted during development. In addition,

5

Figure 1.2. Comparison of mouse stem cell states. Naïve ESCs (left) and primed
EpiSCs (right) represent separate morphological appearances and different pluripotency
states13.

stem cells may be isolated from developmental stages other than the blastocyst, notably
from the mouse post-implantation late epiblast. The resulting cells, termed EpiSCs, are
isolated from the post-implantation embryo and can also be obtained in culture by treating
ESCs with Fibroblast Growth Factor 2 and Activin A13. Mouse EpiSCs exhibit a much
flatter appearance in comparison to naïve ESCs and are thus more analogous to human
ESCs in terms of both their morphological and pluripotent states14 (Fig 1.2).

1.4 Post-Implantation Embryonic Development
Subsequent stages of vertebrate embryo development are initiated as stem cells of the
blastocyst inner cell mass segregate to form epiblast and hypoblast layers, with epiblast
cells eventually forming the embryo proper15. Gastrulation then initiates the migration of
epiblast cells through the primitive streak during which differential cell fate determination
organizes the three embryonic germ layers: ectoderm, mesoderm and endoderm. The
vertebrate embryo develops and matures in an anterior-to-posterior manner, meaning the
most immature cells are found in the posterior, or caudal, region where tailbud elongation
occurs. The caudal epiblast contains a progenitor population that self-renews within the
6

tailbud to ensure that a sufficient supply of cells is added to the developing germ layers as
embryo elongation progresses16. Concurrently, the newly forming mesoderm is further
divided into specific subtypes, including the presomitic, intermediate and lateral plate
mesoderm regions, dependent on local morphogen signaling gradients17.

The skeleton is derived from three distinct embryonic lineages. Craniofacial
structures are mostly derived from the cranial neural crest along with some contribution
from the anterior paraxial mesoderm18,19. The appendicular skeleton is derived from lateral
plate mesoderm20, while the axial skeleton is largely derived from paraxial mesoderm with
the exception of the intervertebral disc, which in mammals is derived from notochord
cells21–23. Newly formed paraxial mesoderm, also called presomitic or unsegmented
mesoderm, is a multipotent embryonic tissue that is formed during vertebrate gastrulation
and is sustained through proliferation and migration of cells from the caudal progenitor
zone of the tailbud as embryogenesis progresses24. Paraxial mesoderm (PM) cells are
mesenchymal and motile and express the early mesodermal marker Brachyury (T), as
well as T-Box6 (TBX6), a gene essential for PM formation and prevention of neural cell
fate via antagonism of SOX2 expression25. PM cells gradually shift from a posterior to
anterior fate as the vertebrate axis extends caudally. The presomitic mesoderm begins to
epithelialize and becomes segmented; progressively forming paired somites flanking the
neural tube (Fig.1.3). Individual somites undergo further specification to form cellular
compartments known as the sclerotome, syndetome, myotome and dermatome, which
contain the precursors for cartilage and bone, tendon, skeletal muscle and skin,
respectively.

7

Figure 1.3. Paraxial mesoderm formation and segmentation. (Left) Paraxial
mesoderm forms alongside the vertebrate neural tube and matures into somites. (Right)
View of the elongating embryonic anteroposterior axis showing the presomitic mesoderm
progenitor pool extending anteriorly from the tailbud region. Cells reaching the
‘determination front’ (blue) are primed for epithelialization and somite segmentation26,27.

1.5 Paraxial Mesoderm Specification and Maturation
Pluripotent stem cells are a valuable model for studying development and disease
and may be the ideal cell source for generating therapeutic progenitors. In terms of
skeletal biology and orthopedic applications, we have been interested in understanding
how to differentiate embryonic stem cells (ESCs) into paraxial mesoderm. The paraxial
mesoderm is an embryonic tissue that gives rise to all of the cartilage, bone, skeletal
muscle, and tendons that make-up the axial skeleton. Because of it embryonic
importance and vast potential, there has been an increasing focus on studying the
mechanisms underlying paraxial mesoderm formation. Two transcription factors, T-box 6
(Tbx6) and Mesogenin (Msgn) are pivotal regulators in the transition of caudal epiblast
8

cells into unsegmented paraxial mesoderm, which is also known as presomitic mesoderm
(PSM). Tbx6 represses Sox2 expression to direct caudal epiblast cells into the paraxial
mesoderm lineage 28,29. The requirement for proper Tbx6 expression was demonstrated
in mouse knockouts where ectopic neural tubes formed at the expense of paraxial
mesoderm formation in the absence of Tbx630. Msgn regulates progenitor cell migration
out of the tailbud and initiates their specification into PSM, and is therefore critical for
balancing paraxial mesoderm specification and maintenance of the caudal progenitor
population 31,32. Thus, proper embryo elongation and axis patterning are maintained
through precise control of paraxial mesoderm differentiation and maturation coordinated
by the expression of Tbx6 and Msgn.

Wnt and FGF signaling pathways also have essential roles in the lineage
specification and outgrowth of axial progenitor cells. A phenotype similar to loss of Tbx6 in
which epiblast cells are forced into the neural ectoderm fate occurs at the expense of
paraxial mesoderm formation in both Wnt3a-null33 and Lef1/Tcf1 double mutant mice34.
In fact, mesoderm formation in general is dependent upon canonical Wnt signaling as
demonstrated by Wnt3, β-Catenin, and LRP5/LRP635–37 knockout studies, showing that
Wnt pathway stimulation is critical for differentiation into the mesoderm lineage. While
Wnt signaling will induce mesoderm, more robust pathway activation via differentiation
with Wnt3a ligand and/or GSK3β antagonists promotes formation of paraxial mesoderm
over other mesoderm types38–42. FGF signaling regulates several critical processes during
embryonic development including germ layer formation during gastrulation and the
specification and maintenance of the tailbud progenitor population43,44. Mesoderm
formation is initiated by FGF signaling in epiblast cells which triggers migration through
the primitive streak15,45,46. Embryonic knockouts of Fgf4, Fgf8, Fgfr1, or Fgfr2 are all early
embryonic lethal 47–50, primarily due to failure of mesoderm formation and severe caudal
9

truncations caused by absence of the migratory and self-renewal cues supplied by the
FGF signaling pathway.

The somitogenesis phase follows paraxial mesoderm formation, as somite pairs
form at the anterior-most region of the presomitic mesoderm. Maturing PSM cells
undergo cyclical epithelialization creating the segmental border of each somite. This
periodic segmentation occurs under the control of two important transcription factors,
Mesp2 and Ripply2, whose expression controls the size and organization of each somite
pair51,52. Mesp2 and Ripply2 establish the anterior boundary of the presomitic mesoderm
by acting as negative regulators of Tbx6 expression. In the anterior PSM,Tbx6 in
conjunction with Notch signaling negatively regulates its own expression by inducing
Mesp2 expression which in turn activates Ripply2 expression53,54. Mesp2 and Ripply2
cause Tbx6 degradation, while Ripply2 also downregulates Mesp2 expression to complete
somite patterning 55,56. Perhaps the most important modulator of the eventual maturation
and segmentation of the PSM is the increasing concentration of retinoic acid affecting cell
fate in this region of the embryo.

1.6 Retinoic Acid Receptor Signaling
Retinoic Acid Receptors (RARα,β,γ) function as transcription factors that
participate in numerous developmental and disease processes. Considerable attention
has been given to how retinoic acid (RA) binding to RARs regulates their transcriptional
function, however much less is understood about how RARs function in the absence of
RA. RA signaling is mediated by nuclear RARs that complex with retinoid X receptors
(RXRs) and act as transcription factors that associate with various coactivator or
corepressor complexes to regulate gene expression. The RAR-RXR dimers bind to
hexameric direct nucleotide sequence repeats known as RA response elements (RAREs)
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within regulatory regions of RA-responsive genes. Generally, absence of RA ligand leads
to recruitment of repressive transcriptional cofactors, while RA-RAR binding typically
activates target gene transcription through recruitment of co-activators. However, this
mechanism is reversed for certain genes, including Fgf8 and others involved in cell
pluripotency and proliferation, which are repressed as a result of RA-RAR binding57,58.
This modality underscores the primary role of RA ligand in triggering differentiation via
activation of cell-type specific genes through RARs, while simultaneously suppressing
transcription of pluripotency-related genes, also through RARs. The pleiotropic effects of
RA may be due to interaction of separate RAR subtypes or isoforms with the opposing
target gene types.

Animal models deficient in RA due to loss of genes required for synthesis of RA
from vitamin A, including Raldh2, exhibit ectopic, anterior Fgf8 expression leading to
expansion of the caudal progenitor population and disruption of somitogenesis59.
Conversely, animals lacking Cyp26a1, which encodes an RA-degrading enzyme, suffer
premature progenitor differentiation leading to an anteriorization of cell fate and caudal
truncation defects60. Also, a recent epigenetic study demonstrated that RA directly
represses Fgf8 expression by recruiting polycomb complexes and triggering histone
modifications near its upstream RARE leading to a repressive chromatin state61.

Genes located on three separate chromosomes encode three distinct human RAR
subtypes (α, β, γ), and each subtype has multiple isoforms due to alternative splicing.
The DNA binding and ligand binding domains, denoted as regions C and E, respectively,
are highly conserved between subtypes and throughout evolution (Fig 1.4). The A/B
region located within the N-terminal domain varies widely between subtypes and between
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Figure 1.4. Retinoic Acid Receptor Structure and Signaling. (A) Basic structure of
retinoic acid receptors. Sequence variations in the A/B region delineate the alpha, beta
and gamma subtypes, while other domains are highly conserved62. (B) RA ligand
binding to RARs recruits co-activator binding to activate transcription of certain target
genes. Co-repressor binding in the absence of ligand is also an important mechanism
for transcriptional repression in the absence on RA ligand63.

subtype isoforms but plays a key role in regulating RA target gene transcription.
Interestingly, the A/B region of RAR proteins contains a ligand-independent transcription
activating function (AF-1), and a semi-conserved proline-rich motif of the B region
contains phosphorylation sites which may influence DNA binding, co-regulator
interactions, or degradation64. The ligand-independent activity of RARs, and the fact that
the AF-1 domain is found in a region of high variance between subtypes, is intriguing and
reinforces the rationale behind our belief that RARγ signaling is of particular importance
for specification of paraxial mesoderm, even in a region of the embryo, and likewise in our
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cell culture system, where RA ligand is absent. Finally, regarding the axial skeleton
beyond the presomitic mesoderm phase, RAR signaling plays critical roles in
somitogenesis, chondroprogenitor specification, and postnatal bone maintenance63,65,66.

1.7 Research Innovation
The innovation of this thesis lies in our overall research approach, which has focused on a
specific skeletal lineage combined with the utility of fluorescent reporter stem cell lines
which help expedite our progress towards understanding the complexities inherent to
stem cell differentiation. Few established differentiation protocols focus on transitioning
between distinct stages of cell development, and even fewer emphasize the role of
retinoic acid receptor signaling during stem cell differentiation. We demonstrate the
importance of the stem cell state on mesoderm induction and the influence early cell fate
decisions have on downstream differentiation potential. This work has added to the
fundamental knowledge of skeletal stem cell derivation and established an early
developmental roadmap for generating therapeutically relevant skeletal progenitor cells.
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CHAPTER 2

SPECIFIC AIMS
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SPECIFIC AIMS

Treatment of severe musculoskeletal injuries is currently limited to surgical
intervention and reliance on natural healing processes during recovery, which are not
always sufficient to repair critical tissue defects. Various cell-based approaches for repair
augmentation have been gaining traction, however a reliable cell therapy approach,
without the need for concurrent application of growth factors carrying potential for offtarget effects, has not been realized.

The long-term goal of our research is to develop a cell therapy approach to
regenerate bone tissue without the need for administration of high-dose growth factors,
which can cause repair to go haywire, leading to poor quality, ectopic bone formation.
Our strategy utilizes pluripotent stem cells, which are capable of forming all cell types
within the body, to specifically generate forerunners of osteoblasts, the cells responsible
for creation of new bone.

The skeleton is derived from three distinct embryonic precursors, neural crest,
lateral plate mesoderm, and paraxial mesoderm. Out of these three lineages, we have
been compelled to investigate paraxial mesoderm formation because paraxial mesoderm
entirely contributes to the cartilage, bone, tendon, and muscle that comprise the axial
skeleton. Thus, the benefit of investigating mechanisms underlying paraxial mesoderm
formation is that it may lead to discovery of novel methods for generating a variety of
clinically applicable skeletal cell types.

To approach these studies using an in vitro culture system, we have genetically
engineered mouse and human pluripotent stem cell lines that produce fluorescent proteins
15

of key gene markers of paraxial mesoderm formation. This allows us to visualize cellular
differentiation in real time and provides an ability to have a rapid diagnostic readout on the
effectiveness of our experimental conditions.

Our work has led us to become very interested in the function of Retinoic Acid
Receptors (RAR) in the absence of Retinoic Acid (RA) during the early stages of
embryogenesis leading up to the formation of paraxial mesoderm. Our preliminary studies
show that treatment with AGN193109, an RAR inverse agonist, along with canonical Wnt
pathway and fibroblast growth factor (FGF) pathway stimulation promotes the formation of
paraxial mesoderm.

The aims of this thesis will further investigate how AGN193109 promotes paraxial
mesoderm formation by: (1) Determining what cellular stage(s) do RARs function in the
absence of RA to promote paraxial mesoderm formation; and (2) Identifying which RARs
function in the absence of RA to promote paraxial mesoderm formation.

Our central hypothesis: RARs function in the absence of RA during the
transition from caudal epiblast to presomitic mesoderm to promote paraxial
mesoderm formation from pluripotent stem cells.

16
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INVERSE AGONISM OF RETINOIC ACID RECEPTORS DIRECTS EPIBLAST CELLS
INTO THE PARAXIAL MESODERM LINEAGE

Ryan P. Russell, Yu Fu, Yaling Liu, Peter Maye
Department of Reconstructive Sciences
School of Dental Medicine
University of Connecticut Health Center
United States

This work has been previously published as an open access article in the journal:
Stem Cell Research
DOI: 10.1016/j.scr.2018.05.016

Abstract
We have investigated the differentiation of paraxial mesoderm from mouse embryonic
stem cells utilizing a Tbx6-EYFP/Brachyury (T)-Cherry dual reporter system.
Differentiation from the mouse ESC state directly into mesoderm via Wnt pathway
activation was low, but augmented by treatment with AGN193109, a pan-retinoic acid
receptor inverse agonist. After five days of differentiation, T+ cells increased from 12.2% to
18.8%, Tbx6+ cells increased from 5.8% to 12.7%, and T+/Tbx6+ cells increased from
2.4% to 13.1%. The synergism of AGN193109 with Wnt3a/CHIR99021 was further
substantiated by the increased expression of paraxial mesoderm gene markers Tbx6,
18

Msgn1, Meox1, and Hoxb1. Separate to inverse agonist treatment, when mouse ESCs
were indirectly differentiated into mesoderm via a transient epiblast step the efficiency of
paraxial mesoderm formation markedly increased. Tbx6+ cells represented 65-75% of
the total cell population after just 3 days of differentiation and the expression of paraxial
mesoderm marker genes Tbx6 and Msgn increased over 100-fold and 300-fold,
respectively. The further evaluation of AGN193109 treatment on the indirect
differentiation protocol suggested that RARs have two distinct roles. First, AGN193109
treatment at the epiblast step and mesoderm step promoted paraxial mesoderm formation
over other mesoderm and endoderm lineage types. Second, continued treatment during
mesoderm formation revealed its ability to repress the maturation of presomitic mesoderm
into somitic paraxial mesoderm. Thus, the continuous treatment of AGN193109 during
epiblast and mesoderm differentiation steps yielded a culture where ~90% of the cells
were Tbx6+. The surprisingly early effect of inverse agonist treatment at the epiblast step
of differentiation led us to further examine the effect of AGN193109 treatment during an
extended epiblast differentiation protocol. Interestingly, while inverse agonist treatment
had no impact on the conversion of ESCs into epiblast cells based on the expression of
Rex1, Fgf5, and pluripotency marker genes Oct4, Nanog, and Sox2, after three days of
differentiation in the presence of AGN193109 caudal epiblast and early paraxial
mesoderm marker genes, T, Cyp26a1, Fgf8, Tbx6 and Msgn were all highly up-regulated.
Collectively, our studies reveal an earlier than appreciated role for RARs in epiblast cells
and the modulation of their function via inverse agonist treatment can promote their
differentiation into the paraxial mesoderm lineage.
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3.1. Introduction
The differentiation of pluripotent stem cells can be used as a valuable approach to
study development, disease and obtain therapeutic progenitor cells. Our interest in
skeletal biology has motivated us to learn how to differentiate embryonic stem cells
(ESCs) into paraxial mesoderm. The paraxial mesoderm is a highly desirable cell
population to generate because it is the precursor that gives rise to all of the cartilage,
bone, skeletal muscle, and tendons that make-up the axial skeleton.

An increasing body of work has provided crucial insight into the mechanisms that
instruct paraxial mesoderm formation. Two transcription factors, T-box 6 (Tbx6) and
Mesogenin (Msgn) are pivotal regulators in the transition of caudal epiblast cells into
unsegmented paraxial mesoderm, which is also known as presomitic mesoderm.
Targeted loss of Tbx6 in mice resulted in the formation of ectopic neural tubes at the
expense of paraxial mesoderm formation 30. Tbx6 represses Sox2 expression to direct
caudal epiblast cells into the paraxial mesoderm lineage 28,29. Msgn orchestrates the
differentiation and migration of progenitor cells exiting the tailbud which form the
presomitic mesoderm, and is therefore critical for balancing paraxial mesoderm
specification and maintenance of the caudal progenitor population 31,32. Together, Tbx6
and Msgn control the differentiation and maturation of paraxial mesoderm required for
proper embryo elongation.

Wnt and FGF signaling pathways have essential roles in the lineage specification
and outgrowth of axial progenitor cells. Targeted loss of Wnt3a 33 and Lef1/Tcf1 double
mutants 34 resulted in a phenotype similar to loss of Tbx6 in that broader contribution of
epiblast cells into the neural ectoderm fate at the cost of forming paraxial mesoderm. With
that in mind, there is an overwhelming amount of genetic and biochemical data showing
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that canonical Wnt signaling plays a major role in mesoderm formation. Gene targeting
studies in mice have shown how several members of the Wnt pathway are required for
mesoderm formation including, Wnt3, β-Catenin, and LRP5/LRP6 double mutants 35–37.
During ESC differentiation, Wnt3a and GSK3β antagonists are commonly used to induce
mesoderm formation with higher levels of canonical Wnt activity promoting the formation
of paraxial mesoderm 38–42. FGF signaling is indispensable during embryogenesis, as
knockouts of Fgf4, Fgf8, Fgfr1, or Fgfr2 are all early embryonic lethal 47–50, and dominant
negative mutants display disruption of gastrulation cell movements, lack of mesoderm
specification, and severe caudal truncation 43,44. FGF signaling in epiblast cells promotes
migration through the primitive streak to initiate mesoderm formation and patterning, and a
high FGF concentration persists in the tailbud to maintain the pluripotency and
proliferation of cells contributing to the posterior paraxial mesoderm 15,45,46. Subsequent to
presomitic mesoderm formation, a cyclical process of maturation occurs that involves
periodic segmentation to form paired somites. Two important transcription factors Mesp2
and Ripply2 are critical in forming the segmental border at the anterior most region of the
presomitic mesoderm thereby controlling the size and organization of each somite

51,52

.

Functioning as negative regulators, Mesp2 and Ripply2 establish the anterior boundary of
Tbx6, and therefore mark the extent of the presomitic mesoderm domain. A negative
feedback loop exists in the PSM wherein Tbx6, along with Notch signaling, induces
Mesp2 expression which in turn induces Ripply2 expression 53,54. Mesp2 and Ripply2
cause Tbx6 degradation, while Ripply2 also downregulates Mesp2 expression to complete
somite patterning 55,56.

The maturation of paraxial mesoderm is also highly regulated by Retinoic Acid
(RA) signaling. At the caudal end of the developing embryo, Cyp26a1, a gene that
encodes for an enzyme which breaks-down retinoic acid, is expressed thereby specifying
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a region absent of RA signaling 67. Targeted loss of Cyp26a1 results in severe caudal
truncation, which mimics defects caused by teratogenic levels of RA 60,68. Examination of
Wnt3a and FGF8 expression in Cyp26a1 mutants, genes normally expressed at the
caudal end and important for driving axial outgrowth were down-regulated. However, as
the anterior most region of presomitic mesoderm distances itself from the caudal end
where Cyp26a1 is expressed, levels of RA signaling increase in conjunction with the
formation of somites and Meox1 expression 69,70. Aldh1a2, a gene that encodes for an
enzyme responsible for RA synthesis is highly expressed in the somites and is necessary
for proper somite development 58. Interestingly, of the three Retinoic Acid Receptors
(RARα,β,γ), RARγ and RARβ are expressed in distinct zones that correspond with the
caudal tail and trunk region, zones retaining low and high retinoic acid signaling,
respectively.

In this study, we have undertaken efforts to direct mouse ESCs into paraxial
mesoderm. Our work has led us to become very interested in the role of RARs in this
process. Here we present evidence that inverse agonism of RARs via treatment of
AGN193109, a pan-RAR inverse agonist in epiblast cells and nascent mesoderm
promotes their differentiation into paraxial mesoderm.
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3.2. Materials and Methods

3.2.1. Cell Culture
Mouse ESCs were maintained on 0.1% gelatin coated tissue culture dishes
(Thermo Scientific) and grown in serum free media containing a 1:1 mixture of DMEM/F12
and Neurobasal medium (Life Technologies), N2 and B27 supplements, 0.05% BSA,
100U/ml penicillin, 100µg/ml streptomycin, 1.5x10-4 M monothioglycerol, 3uM CHIR99021
(Stemgent), 1uM PD0325901 (Cayman Chemical), and 10ng/ml LIF (Millipore)71,72. For
differentiation, mouse ESCs were seeded on tissue culture dishes coated with Geltrex
(Gibco) and grown for a minimum of 24 hours in maintenance media. For differentiation,
cells were grown in a 3:1 mixture of IMDM and Ham’s F12 (Life Technologies) N2, B27
without vitamin A, 0.05% BSA, 100U/ml penicillin, 100µg/ml streptomycin, 1.5x10-4 M
monothioglycerol, and 0.5mM ascorbic acid. For mesoderm differentiation, 50ng/ml Wnt3a
(PeproTech), 3uM CHIR99021 (Stemgent), 1uM AGN193109 (Santa Cruz Biotechnology),
10ng/mL FGF2 and 100ng/ml Noggin (PeproTech) were added in different combinations.
Epiblast induction was carried out in differentiation media containing 10ng/mL FGF2 and
10ng/mL Activin A (R&D Systems), with or without 1uM AGN193109 for the indicated
durations. Note: While initial experiments used both Wnt3a and CHIR99021, it was
determined that the potency of this combination was negligible to that of CHIR99021
alone. Subsequent experiments utilized CHIR99021 without the addition of Wnt3a.

3.2.2. Generation of Fluorescent Reporter ESC Lines
For the creation of Tbx6-EYFP/T-Cherry dual reporter mouse ESCs, a BAC clone
CTD-2379F21 (Children’s Hospital Oakland Research Institute) containing the Brachyury
gene was engineered with a Cherry fluorescent reporter gene using bacterial
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recombination strategies as previously described73. In brief, a homology arm was PCR
amplified from the BAC clone using Pfx DNA polymerase (Life Technologies) with primers
5’-CTCTGCGGCCGCACTGAATTTCGGTCCCCAGAGA-3’ (sense),
5’-CTCTGGATCCGAAGCCCAGACTCGCTACCTGA-3’ (antisense). The DNA fragment
was cloned into the Not1-BamH1 site of pLD53.SC2-Cherry and Rec A was used to
integrate the reporter into the BAC clone. The BAC clone was then retrofitted with
puromycin resistance through Cre/LoxP recombination by co-electroporating pCTP, which
expresses Cre recombinase and pUni, which contains an EF1α-puromycin resistance
gene and a LoxP site into CTD-2379F21 competent bacteria. Purified BAC was
transfected into Tbx6-H2B-EYFP ESCs (generously provided by Sonja Nowotschin and
Katerina Hadjantonakis 74) using Lipofectamine 2000 (Life Technologies) and clones were
enriched by puromycin selection and screened for the transgene by PCR genotyping
using:
5’-CTCTGCGGCCGCACTGAATTTCGGTCCCCAGAGA-3’ (sense) and
5’-GCACCTTGAAGCGCATGAACTCCTTGATGA-3 (antisense). Reporter expression was
observed in individual clones by in vitro differentiation to select for optimal expressing cell
lines.

3.2.3. FACS Sorting and Analyses
ESCs were washed twice with cold PBS then digested using Accutase (StemCell
Technologies) and centrifuged at 300g for 5 minutes. Cells were then resuspended in FACS
staining buffer (PBS, 0.5% BSA, 2 mM EDTA, pH 7.2) and sorted for Tbx6-EYFP and TCherry reporter expression. FACS sorting was carried out using a FacsAria II
For FACS analyses, cells were harvested in the same fashion as sorting, but were analyzed
on a Becton-Dickinson LSRII flow cytometer. FACS sorting and analyses were carried out
at the UCHC Flow Cytometry Core.
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3.2.4. RNA Purification and Quantitative RT-PCR
RNA purification was carried out using the NucleoSpin RNA kit (Macherey-Nagel) according
to manufacturer’s recommendations, including a genomic DNA digestion step. cDNA was
prepared from 500 ng of RNA/sample using the ProtoScript II Reverse Transcriptase (New
England BioLabs). QPCR was carried out using SybrGreen PCR Master Mix (BioRad) in an
ABI 7900HT (Applied Biosystems). PCR primer sequences for gene expression analyses
were designed using qPrimer Depot

75

(http://mouseprimerdepot.nci.nih.gov/), a database

of optimized primers for RefSeq genes.

3.2.5. Microscopy and Imaging

Cells in culture were imaged using a Zeiss Observer Z.1 inverted microscope.
Fluorescence was detected using the following filter sets (Chroma Technology):
HQ 500/20, HQ535/30, Q515lp, for EYFP, and HQ577/20x, HQ640/40m, Q595lp
for Cherry fluorescent protein. Images were captured using an Axiocam MRc
digital camera and Zen software (Zeiss).

3.2.6. Statistical Analyses

Quantitative realtime PCR data are presented as mean ± standard error of the mean
(SEM). Differential gene expression between groups was statistically analyzed with
a t test (CFX Manager Software 3.1; Bio-Rad Laboratories, Munich, Germany).
Differences were considered statistically significant at P < .05 (*).
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Table 3.1. Mouse QPCR Primers
Gene
Symbol
Gapdh
Tbx6
Msgn1
Hoxb1
Meox1
Sox2
T
Fgf8
Wnt3a
Mesp2
Ripply2
Mixl1
Eomes
Lhx1
Fgf5
Nanog
Oct4
Cyp26a1
Rex1

Sense (Forward)

Antisense (Reverse)

Species

5’-CGTCCCGTAGACAAAATGGT-3’
5’-TGACAGCCTACCAGAACCCT-3’
5’-AACCTGGGTGAGACCTTCCT-3’
5’-TTCGACTGGATGAAGGTCAA-3’
5’-GCCAATGAGACGGAGAAGAA-3’
5’-ACAAGAGAATTGGGAGGGGT-3’
5’-GTCTAGCCTCGGAGTGCCT-3’
5’-GCTCATTGTGGAGACCGATA-3’
5’-ACTACGTGGAGATCATGCCC-3’
5’-TGGACACAATCCACTGAACC-3’

5’-TTGATGGCAACAATCTCCAC-3’
5’-CCCGAAGTTTCCTCTTCACA-3’
5’-TCCGCATCCTGAGTTTCTCT-3’
5’-GGTGAAGTTTGTGCGGAGAC-3’
5’- TTGGTGAAGGCTGTCCTCTC-3’
5’-AAGCGTTAATTTGGATGGGA-3’
5’-CCATTGCTCACAGACCAGAG-3’
5’- AATACGCAGTCCTTGCCTTT-3’
5’- GGTGGCTTTGTCCAGAACAG-3’
5’-GGCTGTAGTCTCTGGCATGA-3’
5’-GGTACCCGGGCTGCGCGGAC-3’
5’-CCTTGAGGATAAGGGCTGAA-3’
5’-GACCTCCAGGGACAATCTGA-3’
5’-AACCAGATCGCTTGGAGAGA-3’
5’- ACAGTCATCCGTAAATTTGGC-3’
5’-GTGCTGAGCCCTTCTGAATC-3’
5’-TTCTAGCTCCTTCTGCAGGG-3’
5’-ATCACCTTCTTTCGCTGCTT-3’
5’-GTCCCATCCCCTTCAATAGCAC-3’

Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse

5’-ATGGATACCACCGAGAGCGCCGAGA-3’

5’-CGACAGACCATGTACCCAGA-3’
5’-GGCCTACCAAAACACGGATA-3’
5’-TGTAAATGCAACCTGACCGA-3’
5’-GCTGTGTCTCAGGGGATTGT-3’
5’-AAGTACCTCAGCCTCCAGCA-3’
5’-AGAGGGAACCTCCTCTGAGC-3’
5’-GCAGGAAATACGGCTTCATC-3’
5’-TGAAAGTGAGATTAGCCCCGAG-3’
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3.3. Results

3.3.1. Examination of Paraxial Mesoderm Induction in a Dual Reporter Mouse ESC
Line
To investigate the process of paraxial mesoderm formation from mouse ESCs, we
obtained a T-box 6-H2B-EYFP (Tbx6-EYFP, green) knock-in ESC reporter line74 and
introduced a Brachyury-Cherry BAC reporter (T-Cherry, red) into this cell line to generate
dual reporter T-Cherry/Tbx6-EYFP ESCs (Fig.3.1A). During embryogenesis, Brachyury is
transiently, but broadly expressed across many different mesoderm subtypes76, while
Tbx6 is more selectively expressed in early forming paraxial mesoderm cells77. To verify
reporter line functionality, mesoderm formation was induced by activating Wnt signaling as
previously reported38–42. For differentiation, mouse ESCs were seeded at low density and
allowed to attach and grow for two days. After two days, canonical Wnt signaling was
activated via the addition of Wnt3a (50ng/ml) and/or CHIR99021 (3uM) over the next four
days (days 2-6, Fig.3.1). As anticipated, Wnt pathway activation increased the expression
of both reporters over the four-day treatment period. Interestingly, the location and
organization of cells expressing T and Tbx6 reporters were noticeably different (Fig.3.1,
C-E). Strong T-Cherry reporter expression appeared at the center of the colony and this
group of cells over time increased three dimensionally in size as a spherical mass. In
contrast, the majority of Tbx6+ cells were present around the periphery as a flatter cellular
monolayer. At earlier stages of differentiation, weak T-Cherry reporter expression could
also be detected in the Tbx6+ cell population (Fig.3.1, C1-C3).

To confirm the fidelity of reporter expression, cultures were FACS sorted for Tbx6+
and T+ cells and endogenous gene expression for these respective reporters were
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Figure 3.1
28

Figure 3.1. Paraxial mesoderm induction in a Tbx6 and Brachyury dual reporter
mouse ESC model. (A) DNA maps of reporter genes and mesoderm differentiation
strategy. Tbx6-H2B-EYFP was targeted into the endogenous gene locus as previously
described [1]. The Brachyury-Cherry reporter was introduced into ESCs as a BAC
transgene. Established stem cells were plated for differentiation and allowed to adjust to
the base differentiation media for two days, followed by four days of differentiation with
mesoderm inducing factors. (B-E) Imaging of Tbx6 (green) and Brachyury (red) reporter
expression during ESC differentiation in response to Wnt3a and CHIR99021 from days 2
to 6. (C1-C3) Imaging of reporter expression at higher magnification on day 4 suggests
that Tbx6+ and Brachyury+ cells are largely distinct populations. (F) Gene expression
analyses on sorted cell populations confirms the fidelity of reporter expression with
endogenous gene expression and enrichment of paraxial mesoderm genes in the Tbx6+
population. Data shown as mean ± SEM (n = 3, *p < .05, where * denotes the comparison
of T+ to Tbx6+).
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examined (Fig.3.1, D and E). T was ~33 fold higher in the T-Cherry population compared
to Tbx6-EYFP cells. In contrast, Tbx6 was nearly ~30 fold higher in the Tbx6-EYFP
population compared to T-Cherry cells. Given our interest in paraxial mesoderm, we also
examined the expression of Mesenchyme Homeobox 1 (Meox1), Hoxb1, and Mesogenin
(Msgn1) and found that all three gene markers were highly enriched in the Tbx6+ cell
population (Fig.3.1F). Thus, the gene expression analyses on sorted T and Tbx6 cell
populations supported the fidelity of these reporter genes.

3.3.2. Inverse Agonism of Retinoic Acid Receptors Augments Mesoderm Induction
A large body of work has demonstrated the importance of repressing retinoic acid
signaling for proper tail bud elongation60,67,68,78,79. Additionally, repression of BMP signaling
has also been shown to promote the formation of paraxial mesoderm over lateral plate
mesoderm41,80. Therefore, we decided to test AGN193109, a pan-RAR inverse agonist
and Noggin, a BMP inhibitor, for their ability to promote paraxial mesoderm formation in
the presence and absence of Wnt3a/CHIR99021 treatment. Gross evaluation of Tbx6
reporter expression (Fig.3.2 A-H, green) in living cultures only 2 days after treatment
revealed a noticeable benefit when AGN193109 (1uM) was combined with
Wnt3a/CHIR99021 (Fig.3.2, compare G and H to A-F). In contrast, there was no apparent
benefit to Noggin (100ng/ml) treatment. To more quantitatively assess Tbx6 and T
reporter expression, cultures were harvested and analyzed by FACS analyses three days
after treatment. Consistent with our observations, FACS analyses showed that
AGN193109 significantly augmented the ability of Wnt3a/CHIR99021 to stimulate
mesoderm formation (Fig.3.2. compare G’ and H’ to A’-F’). Relative to Wnt3a/CHIR99021
alone, the addition of AGN193109 not only increased the T+ (12.2% to 18.8%) and Tbx6+
(5.8% to 12.7%) cell populations, but also increased the T+/Tbx6+ (2.4% to 13.1%) cell
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Figure 3.2
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Figure 3.2. Inverse agonism of RARs augments mesoderm induction.
(A-H) Representative images of reporter expression under separate and combined
treatment conditions for Wnt3a/CHIR99021, AGN193109, and Noggin after 2 days of
treatment (day 4 of differentiation). (A’-H’) FACS analyses of Tbx6 and Brachyury reporter
expressing cells after 3 days of treatment (day 5 of differentiation) under the same
treatment combinations as shown in (A). RAR inhibition resulted in substantial increases
in the percentage of Tbx6+, T+, and Tbx6+/T+ cells. Gates were set based on
undifferentiated control stem cells. (I) Gene expression analyses on day 5 for paraxial
mesoderm gene markers Tbx6, Msgn1, Meox1, and Hoxb1 using indicated combinations
of Wnt3a/CHIR99021, AGN193109, and Noggin. Dramatic up-regulation of all paraxial
gene markers was observed when AGN193109 was added with Wnt3a/CHIR99021with or
without Noggin relative to their respective individual treatments. Data shown as mean ±
SEM (n = 3, *p < .05, **p < .05, where * and ** denotes the comparison of treatments
between Wnt3a, CHIR99021 to Wnt3a, CHIR99021 with AGN193109).
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population. However, inverse agonism of RARs alone only had a marginal impact on
mesoderm induction (Fig.3.2C’). FACS analyses also showed that Noggin treated cultures
had no benefit with regard to promoting the early formation of paraxial mesoderm (Fig.3.2,
compare B’ to F’).

The synergism of AGN193109 with Wnt3a/CHIR99021 treatment was also
evaluated by gene expression analyses (Fig.3.2I). For these studies, we examined the
expression of paraxial mesoderm gene markers Tbx6, Msgn1, Meox1, and Hoxb1.
Consistent with the assessment of Tbx6 reporter expression in culture and by FACS
analyses, the combined treatment of AGN193109 with Wnt3a/CHIR99021 substantially
augmented the expression of all four paraxial mesoderm gene markers relative to control
and individual treatments. However, the combined versus individual treatment of
AGN193109 with Wnt3a/CHIR99021 did not increase T expression, which is not restricted
to paraxial mesoderm (data not shown).

3.3.3. Epiblast State Enables More Efficient Differentiation into Paraxial Mesoderm
While Wnt activation in conjunction with RAR inverse agonism did have a
combinatorial benefit to promoting the formation of paraxial mesoderm, the overall
efficiency of differentiating mouse ESCs directly into mesoderm cells was rather modest.
Further, visual aspects of the differentiation process suggested to us that perhaps the
mouse stem cell state was not the ideal “cell state” from which to derive mesoderm. First,
adding Wnt3a and CHIR99021 earlier than day 2 did not result in faster differentiation
(data not shown and Fig.3.3), suggesting drifting away from the stem cell state may be
required for mesoderm formation. Second, even with the delayed addition of Wnt agonists
at Day 2 of culture, the response of mouse ESCs colonies was still quite variable. Some
attached colonies formed spherical mounds with no reporter expression, while other
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Figure 3.3
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Figure 3.3. Conversion of mouse ESCs to epiblast state enhances paraxial
mesoderm differentiation. (A) Schematic depiction of differentiation conditons. Note day
1 conditions for comparing delayed (2i), direct (FC), and epiblast (FA) transitions into
mesoderm. (B) Representative images of reporter expression on day 3 of differentiation
showing robust Tbx6 reporter expression and spreading of T+ cells following epiblast (FA)
transition. T+ cells remained clustered following direct mesoderm induction (FC), with
limited Tbx6 reporter expression. The persistence of numerous mounded, reporternegative colonies occurred with the 2i and FC transitions (white arrows), which were
absent from epiblast-transitioned cultures. (C) Day 3 FACS analysis shows epiblast
transition (FA) followed by two days of mesoderm differentiation generated considerably
more Tbx6+ cells compared to just two (2i) or three (FC) days of mesoderm differentiation,
with control stem cells shown for comparison. (D) Day 3 gene expression indicated
elevated levels of early mesoderm genes T, Wnt3a, and Fgf8 and substantial increases in
the paraxial markers Tbx6 and Msgn with FA transition compared to 2i or FC, which also
retained expression Sox2. Data shown as mean ± SEM (n = 3, *p < .05, where * denotes
the comparison of FA treatment to both 2i and FC).
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colonies formed T+ spherical mounds (Figs.3.1,3.2). We also noted that mouse ESC
colonies that stayed flatter favored the formation of cells expressing the Tbx6 reporter.
This latter detail suggested that first converting mouse ESCs into epiblast-like cells, which
unlike mouse ESCs grow in monolayer, could be more conducive to forming paraxial
mesoderm.

To test this idea, we compared mouse ESCs directly differentiated into mesoderm
to mouse ESCs first differentiated into epiblast-like cells by treating with FGF2 and Activin
A prior to switching to mesoderm conditions (Fig.3.3A). Surprisingly, these studies
revealed that just a single day of differentiation towards the epiblast state followed by
mesoderm induction resulted in a dramatic enhancement in the formation of Tbx6+ cells
(Fig.3.3). Imaging of Tbx6 reporter gene expression two days after mesoderm induction
revealed how transitioning into the epiblast state noticeably increased the abundance of
Tbx6+ cells (Fig.3.3B, compare 2i or FC to FA). More quantitative metrics by FACS
revealed that with one day of epiblast treatment, the percentage of Tbx6+ cells increased
to 65-75% (Fig.3.3C). Gene expression analyses showed paraxial mesoderm marker
genes Tbx6 and Msgn were highly expressed in mesoderm following epiblast
differentiation. In contrast, mouse embryonic stem cells that were transitioned into
mesoderm for two or three days had much lower levels of Tbx6 and Msgn, and retained
expression of Sox2, suggesting many cells in the culture did not undergo mesoderm
differentiation. Consistent with this thinking, FACS analyses and imaging showed a
prevalence of cells expressing neither the T nor Tbx6 reporters following direct
differentiation from mESCs into mesoderm.

36

3.3.4. RAR Inverse Agonist Treatment Suggests Two Distinct Roles Exist in
Regulating Early Paraxial Mesoderm Formation
With the inclusion of an epiblast differentiation step, we decided to revisit the
benefit of treating cells with the RAR inverse agonist AGN193109, which promoted
mesoderm differentiation (Fig.3.2). However, with the addition of an epiblast differentiation
step, we also wanted to determine which stage of differentiation; epiblast, mesoderm, or
both, would inverse agonist treatment be more beneficial. Therefore, we compared the
differentiation of mouse ESCs treated with AGN193109 at the epiblast step (E*),
mesoderm step (M*), or both (E*M*) to ESCs differentiated in the absence of the inverse
agonist (EM) (Fig.3.4A, diagram). Visual examination of cultures showed modest
increases in the level of Tbx6 reporter expression with RAR inverse agonist treatment with
continuous treatment (E*M*) having the brightest level of reporter expression (Fig.3.4B).
FACS analyses substantiated these observations showing the intensity of Tbx6 reporter
expression was considerably higher in E*M* treated cultures compared to EM cultures.
Further, FACS analyses also showed that the continuous RAR inverse agonist treatment
increased the yield of Tbx6+ cells to 90%, compared to 65-75% without treatment.

Gene expression analyses of paraxial gene markers also suggested that RAR
inverse agonist treatment had distinct stage-dependent effects on paraxial mesoderm
formation. While the examination of early gene markers such as Tbx6, Msgn, and Fgf8
showed minimal changes in gene expression, gene markers associated with the transition
of presomitic to somitic mesoderm Mesp2, Ripply2, and Meox1 showed remarkable
changes with inverse agonist treatment. Treatment at the epiblast stage (E*) resulted in
the highest increase in Meox1 expression at the mesoderm stage. However, continuous
RAR inverse agonist treatment (E*M*) had lower levels of Meox1 expression compared to
E*, with Mesp2 and Ripply2 being highly expressed.
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Figure 3.4. Distinct roles of RAR inverse agonist treatment in regulating
paraxial mesoderm formation and maturation. (A) Schematic of differentiation
conditions modifying the strategy of epiblast transition into mesoderm from Fig. 3.3
to assess the stage-dependent effects of AGN193109 treatment as indicated with
asterisks (*). (B) Representative images of reporter expression on day 3 of
differentiation showing continuous RAR inverse agonist treatment (E*M*) having
the brightest level of reporter expression, confirmed by FACS analysis in (C)
comparing E*M* cultures to EM and stem cell control cultures. (D) Gene
expression comparing levels of early gene markers Tbx6, Msgn, and FGF8
showed minimal changes between treatments. However, markers indicating a
transition to somitic mesoderm, Meox1, Mesp2, and Ripply2, were remarkably
higher with inverse agonist treatment, especially with treatment during epiblast
stage. This benefit was also evidenced by the down-regulation of non-paraxial
markers Eomes, Mixl1, and Lhx1 in (E). (F) Model of paraxial mesoderm lineage
differentiation following epiblast transition and the stage-dependent effects of
AGN193109 treatment. Data shown as mean ± SEM (n = 3, *p < .05, **p<0.05,
***p<0.05 where * denotes the comparison of E* to EM, ** denotes the comparison
between M* to EM, and *** denotes the comparison of E*M* to EM).
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In contrast to detecting stable or increasing expression of paraxial mesoderm
marker genes, the expression of lateral plate mesoderm, intermediate mesoderm, and
endoderm marker genes were either not detected or down-regulated (Fig.3.4E). Lateral
plate mesoderm marker genes Tal1 and Kdr were undetectable. Intermediate mesoderm
marker gene Osr1 was undetectable, while Lhx1 (Fig.4E) was down-regulated almost 3fold by inverse agonist treatment just at the epiblast step (E*) and 4-fold with continuous
inverse agonist treatment (E*M*). Genes also important for endoderm specification Eomes
and Mixl1 were down-regulated 4- and 5-fold, respectively by treatment with the inverse
agonist at just the epiblast step (E*).

Taken together, this data suggests that inverse agonism of RARs at the epiblast
stage promotes the future transition of epiblast cells towards the presomitic mesoderm
lineage over other embryonic lineages, but continued treatment at the mesoderm step
represses further maturation into somitic mesoderm (Fig.3.4F). It is well established that
retinoic acid signaling is involved in the maturation of presomitic unsegmented mesoderm
into somitic segmented mesoderm, consistent with the lack of robust Meox1 expression
with continued treatment (Fig.3.4D). Further, this likely explains why the highest
expression levels and percentage of cells with Tbx6 reporter activity were present in the
E*M* treated cultures as it is known that Tbx6 expression decreases during paraxial
mesoderm maturation81.

3.3.5. Inverse Agonism of RARs Directs Epiblast Cells Towards the Paraxial
Mesoderm Fate
With evidence that treatment with AGN193109 at the epiblast step of differentiation
can influence the future differentiation of epiblast cells into paraxial mesoderm, we
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decided to examine the effect of RAR inverse agonist treatment on gene expression
during epiblast differentiation. However, in contrast to the prior experiment where epiblast
differentiation lasted just a single day, we decided to carry out epiblast differentiation for
three days in the presence and absence of inverse agonist treatment (Fig.3.5). The
conversion from the stem cell state to the epiblast state was detected by the rapid down
regulation of the inner cell mass marker gene Rex1 (Fig.3.5A) and the dramatic increase
in the epiblast marker gene Fgf5 (Fig.3.5B). The expression of pluripotency marker gene
Oct4 remained unchanged throughout the three-day period, while Nanog expression
abruptly dropped, but then gradually increased (Fig.3.5C,D). The pluripotency marker
gene Sox2 gradually decreased over the three-day differentiation period with slightly lower
expression levels with inverse agonist treatment. Collectively, the examination of these
gene markers did not reveal any dramatic changes in gene expression in the addition of
AGN193109 treatment.

However, examination of caudal epiblast genes Cyp26a1, T, and Fgf8 and early
markers of paraxial mesoderm Msgn and Tbx6 did reveal that inverse agonist treatment
was somehow promoting meaningful changes in epiblast gene expression (Fig.3.5F-J). By
day three of epiblast differentiation in the presence of inverse agonist treatment, Cyp26a1
and T were 6-fold higher (Fig. 3.5F, G), Fgf8 was 3-fold higher (Fig.3.5H), and Msgn and
Tbx6 were 45- and 9-fold higher, respectively, compared to epiblast conditions alone (Fig.
3.5I, J). This delayed yet pronounced increase in a subset of caudal epiblast marker
genes that are largely responsible for driving axial growth suggests that inverse agonism
of RARs in epiblast cells can promote their direction of differentiation towards the paraxial
mesoderm cell lineage.
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Figure 3.5. Treatment of epiblast cells with RAR inverse agonist favors a paraxial
mesoderm fate. Gene expression analyses over three days of epiblast differentiation with
(FA+AGN) or without (FA) inverse agonist treatment compared to stem cell (2i) control.
(A,B) Rapid loss of Rex1 expression and dramatic increase of Fgf5 expression confirms
transition from stem cell to epiblast. (C-E) Oct4 expression remained unchanged, while a
sharp drop and then gradual increase in Nanog expression, and a steady decrease in
Sox2 expression occurred in FA and FA+AGN conditions alike. (F-H) Caudal epiblast
genes Cyp26a1, T, and Fgf8 were strongly increased over three days of epiblast
differentiation, while including AGN193109 treatment showed even greater enhancement
of expression levels. (I,J) Inverse agonist treatment also led to substantial increases in
paraxial mesoderm markers Msgn and Tbx6 by day 3 of epiblast differentiation not seen in
the FA treatment, suggesting AGN193109 promotes epiblast differentiation into the
paraxial mesoderm lineage. Data shown as mean ± SEM (n = 3, *p < .05, where * denotes
the day 3 comparison between FA to FA with AGN193109).
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3.4. Discussion
In this study, we showed that the differentiation of paraxial mesoderm directly from the
mouse ESC “naïve” state is considerably less efficient than differentiation from the
epiblast state. This work also showed how the use of AGN193109, a pan-RAR inverse
agonist, when added at the epiblast and mesoderm steps of differentiation promoted the
formation of paraxial mesoderm over other mesoderm and endoderm cell lineages.
Further, continued treatment of AGN193109 during mesoderm differentiation repressed
the maturation of presomitic mesoderm into somitic mesoderm. This two-step, three-day
differentiation protocol resulted in an extremely high yield of Tbx6+ paraxial mesoderm
cells (90%) from mouse ESCs. Taken together, this work introduces a novel and efficient
approach to generate paraxial mesoderm from mouse ESCs and suggests a very early
retinoic acid independent role exists for RARs in epiblast cells and early mesoderm
progenitor cells that promotes their differentiation into the paraxial mesoderm lineage.

3.4.1. Epiblast State is a Better Staging Ground for Generating Paraxial Mesoderm
While our studies and work by others 41,42,82,83 have shown that mesoderm
differentiation directly from the mouse ESC naive state is possible, we also demonstrate
how paraxial mesoderm formation initiated after an epiblast transition works with greater
efficiency. We speculate that the likely reason for this relates to the conflicting roles of βCatenin as a factor that promotes both stem cell pluripotency and mesoderm
differentiation 42,84–88. CHIR99021, the GSK3 inhibitor that results in β-Catenin stabilization
is one of two stemness molecules in 2i stem cell maintenance media, but also is a widely
used molecule for mesoderm differentiation 82,89–91. Indeed, at the DNA level, β-Catenin
has been shown to occupy regulatory regions on both stemness and mesoderm inducing
genes in mouse ESCs 86. Further, in naïve cells β-Catenin represses TCF3 function to

44

maintain the naïve state, while TCF3 is important for the transition from naïve to the
primed epiblast state 84,88.

With this in mind, we and others 82,83 have noted that mouse ESCs do not
immediately respond to mesoderm inducing factors, as the removal of pluripotency
conditions for up to 48 hours is often necessary to ensure a higher percentage of cells exit
the stem cell state and effectively respond to mesoderm inducing factors. In contrast, we
show that naïve mouse ESCs can rapidly and uniformly respond to epiblast differentiation
conditions, indicating that FGF and Activin signaling pathways do not provide conflicting
cues that would promote the naïve state, but in fact counter naïve stemness regulators to
allow uniform differentiation into the epiblast state. While pluripotency genes are still
expressed at the epiblast state, how they are regulated has markedly changed and is
independent of β-catenin regulation 14,88,92,93. Thus, the stabilization of β-catenin via
treatment of CHIR99021 at the epiblast stage no longer provides conflicting signals to
promote stemness and mesoderm, thereby allowing efficient mesoderm differentiation to
be initiated.

3.4.2. Inverse Agonism of RARs Steers Epiblast Cells toward a Caudal Fate
In this study we show how the addition of an RAR inverse agonist, AGN193109,
promoted the expression of caudal epiblast marker genes as well as early paraxial
mesoderm marker genes (Fig.3.4). However, the mechanism(s) behind this effect remain
unclear. Work by others has shown that when inverse agonists bind to RARs, a change in
protein structure occurs that stabilizes the association of RARs with transcriptional corepressors NCoR and SMRT 94–98. In contrast, when RA binds to RARs they generally
associate with transcriptional co-activators NCoA. With that in mind, in vivo studies have
shown that RARs are expressed in the epiblast, which is devoid of RA signaling based on
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RARE-LacZ reporter characterization 99. Thus, it is likely that RARs function in the epiblast
in a RA independent manner, but their exact role in the epiblast remains unclear. The
work presented here suggests that RARs may function in the absence of RA to promote
caudal epiblast formation and paraxial mesoderm formation.

It is generally accepted that treatment with RAR inverse agonists is thought to
mimic the unliganded conformation and function of RARs; as in the absence of RA, RARs
have been shown to associate with co-repressors NcoA and SMRT 96–98,100. Therefore, it is
conceivable that differentiation performed in the absence of vitamin A, the precursor to
RA, should mimic the effects of inverse agonist treatment. In support of this thinking,
mouse ESCs deficient of Aldha1, which encodes for an enzyme necessary for the
synthesis of RA, showed substantial up-regulation of early paraxial mesoderm gene
markers Tbx6 and Msgn 101. However, we performed our differentiation studies in vitamin
A deficient media and the addition of inverse agonist still had noticeable benefits to
paraxial mesoderm formation. In fact, the up-regulation of Tbx6 and Msgn during
prolonged epiblast differentiation appeared to be highly dependent on the addition of
AGN193109 (Fig.3.5). With that said, mouse ESCs are commonly maintained in serum
free media containing vitamin A, and retinol derivatives stored inside cells102may persist
over the initial days of differentiation, which may impact early cell fate decisions. Also,
work by others suggests vitamin A is a valuable component to the stemness and growth of
mouse ESCs. RA-independent and possibly RA-dependent roles for vitamin A are
important for maintaining rates of mouse ESC proliferation and pluripotency 103–108.
Therefore, maintaining mouse ESCs in the absence of vitamin A is not likely a viable
option, but could interfere with efficiency of subsequent differentiation steps as our studies
possibly suggest. Thus, the application of RAR inverse agonists to rapidly outcompete any
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effects from low levels of RA to promote paraxial mesoderm differentiation is a simple
solution.
3.4.3. RAR Inverse Agonism Represses Paraxial Mesoderm Maturation
While RAR inverse agonist at the epiblast step of differentiation promoted paraxial
mesoderm induction, our studies also indicated that continuous treatment during the
mesoderm differentiation step delayed further maturation. Continuous inverse agonist
treatment resulted in reduced Meox1 expression, while at the same time generated the
highest percentage of Tbx6+ cells (90%). Consistent with our outcomes, past embryonic
studies have shown that severe axial truncation occurs when excessive levels of retinoic
acid signaling occurs 79. Excessive levels of RA overcome the threshold of Cyp26a1
degradation and bind RARγ resulting in truncation 109. In contrast to RA treatment and
similar to our outcomes, in vivo studies in Xenopus have shown that the addition of panRAR and RARγ specific inverse agonists delayed the maturation of unsegmented paraxial
mesoderm to maintain a caudal progenitor pool 110. While the benefit of continuous
inverse agonist treatment at the mesoderm step could be argued, we believe it is likely
that delaying paraxial mesoderm maturation during embryonic stem cell differentiation will
maintain better synchrony among cells in culture, which will provide a more uniform
cellular response for subsequent differentiation steps.

In these studies, we highlight the benefit of epiblast differentiation and RAR
inverse agonism as an approach to increase paraxial mesoderm formation from mouse
ESCs. By enhancing the guidance of ESCs into paraxial mesoderm, downstream efforts
to generate different skeletal cell types will be improved.

47

Conflict of Interest Statement
The authors have no conflicts to declare.

Acknowledgements
Special thanks to Drs. Sonja Nowotschin and Katerina Hadjantonakis for providing the
Tbx6-H2B-EYFP ES cell line and Dr. Evan Jellison for assistance in the flow cytometry
core. Also, special thanks to the National Institute of Arthritis and Musculoskeletal and
Skin Disease (5R21AR56391-2), the State of Connecticut and Connecticut Innovations
(13-SCA-UCHC-02), and the National Institute for Dental and Craniofacial Research
(5T90DE021989-05) for supporting this work.

Supplemental Figures
The following were included as supplemental data figures in the original published
manuscript.

48

Figure 3.6
49

Figure 3.7
50

Figure 3.6. Individual channel images for paraxial mesoderm induction in a Tbx6
and Brachyury dual reporter mouse ESC model. Imaging of DIC, Brachyury (red) and
Tbx6 (green) and reporter expression during mESC differentiation in reponse to Wnt3a
and CHIR99021 from days 2 to 6. Supplemental figure shows single channel images that
correspond to the merged fluorescent images shown in Fig.3.1B-E.

Figure 3.7. Individual channel images for inverse agonism of RARs augments
mesoderm induction. Imaging of DIC, Brachyury (red) and Tbx6 (green) and reporter
expression during mESC differentiation in reponse to separate and combined treatment
conditions for Wnt3a/CHIR99021, AGN193109, and Noggin after 2 days of treatment (day
4 of differentiation). Supplemental figure shows single channel images that correspond to
the merged fluorescent images shown in Fig.3.2 A-H.
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DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
INTO THE PARAXIAL MESODERM LINEAGE

4.1. Introduction

Embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) technologies
have revolutionized research and development of treatments for many different types of
diseases, including those that impact the human skeleton. However, an essential
prerequisite for using ESCs/iPSCs for these purposes requires an in depth understanding
of how to reliably direct pluripotent stem cells into different skeletal cell types. Many
published methodologies have placed great emphasis on the pluripotency state of
ESCs/iPSCs by either (1) directly differentiating ESCs into mature skeletal cell types2,111
or (2) first differentiating ESCs into mesenchymal stem cells prior to differentiating them
into mature skeletal cell types112,113. Comparatively, fewer studies have acknowledged the
embryonic state of pluripotent cells and made efforts to differentiate ESCs/iPSCs along a
multi-stepped embryonic program. At the same time, most investigators would agree that,
if possible, following an embryonic program would likely yield much greater information
about human skeletal development and likely produce higher quality skeletal progenitors
for therapy.

The skeleton is derived from three distinct embryonic lineages. Craniofacial
structures are mostly derived from the cranial neural crest and with some contribution
from the anterior paraxial mesoderm. The appendicular skeleton is derived from lateral
plate mesoderm. The axial skeleton is largely derived from paraxial mesoderm with the
exception of the intervertebral disc, which is derived from notochordal cells6,7. Out of
these three lineages, we were compelled to investigate paraxial mesoderm formation
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because paraxial mesoderm entirely contributes to formation of the somites, which retain
the precursors to a variety of skeletal lineages including chondrocyte, osteoblast,
tenocyte, myoblast, and dermal fibroblast. Thus, the benefit of investigating paraxial
mesoderm formation is that it may lead to discovering how to generate a variety of
skeletal cell types, not just one.

A large body of knowledge exists regarding how paraxial mesoderm formation
occurs during embryogenesis. A key regulator of paraxial mesoderm specification is the
transcription factor T-box 6 (Tbx6). Quite strikingly, targeted loss of Tbx6 in mice resulted
in the formation of ectopic neural tubes at the expense of paraxial mesoderm formation30.
Recently, the mechanism behind this phenotype was reported where Tbx6 represses
Sox2 to direct caudal epiblast cells into the paraxial mesoderm lineage28. In a similar
fashion, targeted loss of Wnt3a also resulted in broader contribution of epiblast cells into
the neural ectoderm fate at the cost of forming paraxial mesoderm29. In general,
canonical Wnt signaling is essential for mesoderm formation. Gene targeting studies in
mice have shown how several members of the Wnt pathway are required for mesoderm
formation including Wnt3, β-Catenin, Lef1/Tcf1 double mutants, and LRP5/LRP6 double
mutants37,86. Interesting, ESC differentiation work by others has also indicated that the
level of Wnt signaling may be important for the type of mesoderm specified with higher
levels being important for paraxial mesoderm formation.

In contrast to Tbx6 and the Wnt pathway, which promote paraxial mesoderm
formation, retinoic acid, a derivative of vitamin A, at teratogenic levels can cause a variety
of embryonic defects including severe caudal truncation68. During early embryonic
development Cyp26a1, which encodes for an enzyme that breaks-down retinoic acid is
expressed throughout the epiblast and becomes progressively restricted to the anterior
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and caudal ends of the developing embryo. Targeted loss of Cyp26a1, mimics teratogenic
levels of retinoic acid, resulting in severe caudal truncation60. Examination of Wnt3a and
FGF8, genes expressed in the tailbud and essential for paraxial mesoderm formation
revealed their down regulation in Cyp26a1 mutants58,114.

In this study, we have undertaken efforts to direct human ESCs into paraxial
mesoderm. To have a readout for mesoderm and paraxial mesoderm formation, we have
created and utilized a human ESC Tbx6-Cherry/Ubiquitin-C-Citrine transgenic reporter
line. H9 human ESCs. Consistent with work by others, higher levels of Wnt signaling
overall lead to greater mesoderm formation including increased Tbx6 expression.
Additionally, we provide evidence that inhibition of retinoic acid signaling in the presence
of Wnt activation using the small molecule AGN193109 dramatically increases paraxial
mesoderm formation.

4.2. Materials and Methods

4.2.1 Cell Culture
H9 ESCs and Tbx6-Cherry/UbiquitinC-Citrine H9 human ESCs were maintained in
hESC media (mTeSR, Stemcell Technologies) on a feeder layer of irradiated mouse
embryonic fibroblasts or Matrigel. Prior to differentiation of human ESCs, cells were
transitioned to tissue culture dishes (Thermo Scientific) coated with Matrigel (Corning) and
grown for a minimum of 24 hours. For differentiation, cells were grown in a 3:1 mixture of
IMDM and Ham’s F12 (Life Technologies) N2, B27 without vitamin A, 0.05% BSA,
100U/ml penicillin, 100ug/ml streptomycin, 1.5x10-4 M monothioglycerol, and 0.5mM
ascorbic acid. 50ng/ml Wnt3a, 3uM CHIR99021 (Stemgent), 1uM AGN193109 (Santa
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Cruz Biotechnology), and 100ng/ml Noggin (PeproTech) were added in different
combinations.

4.2.2. Generation of Fluorescent Reporter H9 ESC Line
For the creation of Tbx6-Cherry/UbiquitinC-Citrine dual reporter H9 human ESCs,
BAC clone RP11-114A14 (Children’s Hospital Oakland Research Institute) containing the
TBX6 gene was engineered with a Cherry fluorescent reporter gene using bacterial
recombination strategies. In brief, a homology arm was PCR amplified from the BAC
clone using Pfx DNA polymerase (Life Technologies) 5’CTCTGCGGCCGCCCTGCACTTTCCCTCTGTTCACGCTGCT-3’ (sense) and 5’CTCTGGATCCGTTGTAGTTCCGTCTGGCCTCAGGTCT-3’ (antisense). The DNA
fragment was cloned into the Not1-BamH1 site of pLD53.SC2-Cherry and Rec A was
used to integrate the reporter into the BAC clone. The BAC clone was then retrofitted with
puromycin resistance through Cre/LoxP recombination by co-electroporating pCTP, which
expresses Cre recombinase and pUni, which contains an EF1α-puromycin resistance
gene and a LoxP site into RP11-114A14 competent bacteria. A Citrine fluorescent
reporter gene was inserted into a PiggyBac plasmid vector containing the human Ubiquitin
C promoter and a neomycin resistance cassette to create pPB.UbiquitinC-Citrine
(generously provided by Allan Bradley and the Wellcome Trust Sanger Institute). For
lipofection, H9 ESCs were passaged to Matrigel-coated plates grown to 50-70%
confluence. 5 ug purified BAC, 2 ug purified UbiquitinC-Citrine plasmid, and 1 ug
hyperactive piggyBac transposase (generously provided by Nancy L. Craig) expression
vector were co-transfected using Lipofectamine 3000 (Life Technologies) according to
manufacturer protocol. Selection with puromycin (0.25ug/ml) was initiated 3 days after
transfection. Resistant clones were picked and expanded after two weeks (Fig. 4.1).
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4.2.3. FACS Analysis and Sorting
ESCs were washed twice with cold PBS then digested using Accutase (StemCell
Technologies) and centrifuged at 300g for 5 minutes. In brief, cells were resuspended in
100 ul FACS staining buffer (PBS, 0.5% BSA, 2 mM EDTA, pH 7.2) and 2 ul of SSEA4
eFluor 660 (eBioscience) antibody was added to the cell suspension. The cell-antibody
suspension was mixed well and incubated for 10 minutes in the dark at 4°C. Cells were
then washed by the addition of 1-2 ml of buffer and subsequently centrifuged at 300g for
10 minutes. Supernatant was aspirated and the cells were resuspended in 500 ul of
staining buffer for FACS analysis. FACS analyses were carried out on a Becton-Dickinson
LSRII and FACS sorting was carried out using a FacsAria II (UCHC Flow Cytometry
Core).

4.2.4. RNA Purification and Quantitative RT-PCR
RNA purification was carried out using Nucleospin RNA II kit (Macherey-Nagel) according
to manufacturer’s recommendations. cDNA was prepared from 1ug of RNA/sample using
the SuperScript II Reverse Transcriptase (Life Technologies). QPCR was carried out
using SybrGreen PCR Master Mix (Qiagen) in an ABI 7900HT (Applied
Biosystems). PCR primer sequences (Table 4.1) for gene expression analyses were
designed using qPrimer Depot75 (http://primerdepot.nci.nih.gov) a database of optimized
primers for RefSeq genes.

4.2.5. Microscopy and Imaging
Cells in culture were imaged using a Zeiss Observer Z.1 inverted microscope.
Fluorescence was detected using the following filter sets (Chroma Technology): HQ
500/20, HQ535/30, Q515lp, for EYFP, and HQ577/20x, HQ640/40m, Q595lp for Cherry
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fluorescent protein. Images were captured using an Axiocam MRc digital camera and Zen
software (Zeiss).

Table 4.1. Human QPCR Primers
Gene

Sense (Forward)

Antisense (Reverse)

Species

GAPDH

5’-AAGGTGAAGGTCGGAGTCAA-3’

5’-TTAAAAGCAGCCCTGGTGAC-3’

Human

TBX6

5’-CAACTGAAGATTGCAGCCAA-3’

5’-CCGCAGTTTCCTCTTCACAC-3’

Human

MSGN1

5’-GGAATTACCTGCCACCTGTC-3’

5’-GTCTGTGAGTTCCCCGATGT-3’

Human

HOXB1

5’-GGTTAAGAGAAACCCACCCA-3’

5’-CAGTTCTGTCAGCTGCCTTG-3’

Human

MEOX1

5’-GAGAAGAAATCATCCAGGCG-3’

5’-AAGGCCGTCCTCTCCTTG-3’

Human

SOX2

5’-GCGAACCATCTCTGTGGTCT-3’

5’-GGAAAGTTGGGATCGAACAA-3’

Human

Figure 4.1. Generation of dual reporter H9 ESC line. Retrofitting of the mCherry
fluorescent reporter into the TBX6-containing bacterial artificial chromosome via
homologous recombination. Co-transfection of H9 ESCs with the TBX6-mCherry vector,
Ubiquitin Citrine vector and PiggyBac Transposase vector via the Lipofectamine 3000
system created dual reporter clones. Puromycin selection and PCR screening confirmed
genomic integration of reporter constructs115.
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4.3 Results

4.3.1 AGN193109 and Wnt Synergize to Promote Paraxial Mesoderm Differentiation
of H9 ESCs
We engineered H9 human ESCs with a TBX6-Cherry (red) BAC transgene and
UbiquitinC-Citrine (green) defined promoter reporter to investigate the generation of
paraxial mesoderm (Fig. 4.1). For differentiation, H9 cells were passed in small patches
on Matrigel, allowed to recover for one day in stem cell media, then transitioned to a
similar defined media used to differentiate mouse ESCs. Similar to our previous studies
using mouse ESCs, we compared the ability of Wnt3a/CHIR99021 treatment separate
and combined with AGN193109 and Noggin to stimulate paraxial mesoderm formation
based on TBX6 reporter expression (Fig.4.2). After three days of treatment, TBX6
reporter expression was absent in controls (Fig.4.2A) and only weakly detected in the
presence of Wnt3a/CHIR99021 (Fig.4.2B). However, the combined treatment of
Wnt3a/CHIR99021 and AGN193109 resulted in a robust increase in TBX6 reporter
expression (Fig.4.2C). The organization of the differentiating colony shown is
representative of what we have observed in other colonies under these conditions.
Interestingly, Noggin treatment at this stage was largely inhibitory to the formation of
Tbx6+ cells mediated by Wnt activation and RAR inhibition (Fig.4.2D). To more
quantitatively assess the generation of Tbx6+ cells, we carried out FACS analyses of
these different treatments (Fig.4.2). Consistent with our visual observations, roughly 27%
of the total cell population was Tbx6+ when treated with Wnt3a/CHIR99021 and
AGN193109. The addition of Noggin reduced the percentage of Tbx6+ cells to 10%. Less
than 0.1% Tbx6+ cells were detected in control and Wnt3a/CHIR99021 cultures at these
early stages of differentiation.
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Figure 4.2. Retinoic Acid Inverse Agonism Increases TBX6 Reporter Expression.
Fluorescent reporter expression in cultures treated for four days with the indicated
combinations of Wnt3a, CHIR99021, AGN193109, and Noggin. TBX6-mCherry (red) and
UbiquitinC-Citrine (green) reporter expression with corresponding FACS analyses
showing percentages of TBX6+ populations indicated stimulation with Wnt3a and
CHIR99021 coupled with retinoic acid receptor pathway inhibition via AGN193109
resulted in the formation of more robust and organized colonies coupled with a strong
increase in TBX6-mCherry reporter expression. (n = 3). Scale bar = 200µm.
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4.3.2. Gene Expression in FACS Isolated Tbx6+ Cells Supports the Generation of
Paraxial Mesoderm from H9 Cells
To provide greater evidence for the generation of paraxial mesoderm from H9 cells
and also confirm the fidelity of our transgenic reporter line, we carried out gene expression
analyses on Tbx6+ and Tbx6- FACS isolated cell fractions (Fig.4.3). Key regulators of
paraxial mesoderm formation, TBX6 (>300 fold) and MSGN1 (>60 fold) were markedly upregulated in the Tbx6+ cell population. While the expression of MEOX1 (>8 fold), a more
mature marker of paraxial mesoderm was also expressed at higher levels in the Tbx6+ cell
population. A lower enrichment of BRACHYURY expression in Tbx6+ cells is consistent
with our studies in mouse ESCs, which potentially identify other mesoderm populations
where this gene is also expressed (data not shown). Finally, SOX2 expression is
extremely low (~35 fold less) in the Tbx6+ cell fraction, which is consistent with past work
showing that Sox2 repression by TBX6 is necessary for paraxial mesoderm formation28,29.

4.3.3. Effects of cell passage method on stem cell state and downstream
differentiation potential
In an effort to enhance the reproducibility of differentiation studies, we investigated
alternative cell passaging methods to achieve a more consistent plating density and
colony size. We have used Accutase to dissociate colonies into single cells for FACS
analyses; however, the survival of human ESCs is quite poor when plated as single cells.
Prior experiments were begun with ESCs as small patches via the “cut and paste”
method. For this technique, a pipette tip is used to crosshatch stem cell colonies to create
patches ideally containing fewer than 10 cells. The cells are then mechanically lifted from
the plate using a cell scraper and collected for plating of the differentiation experiment.
While the patch passage approach ensures survival, it is very difficult to reliably achieve
uniform colony size and number between individual wells of the culture plate. However,
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Figure 4.3. TBX6 Reporter-Positive Cells Identify Paraxial Mesoderm from Human
ESCs. Replicate cultures sorted for TBX6-mCherry expression following patch passage and
four days of treatment with Wnt3a, CHIR99021 and AGN193109. FACS sorting resulted in
TBX6+ populations of 23.5% and 22.8% of viable cells in each replicate. Positive and
negative sorted populations were analyzed for expression of TBX6 and Mesogenin, master
regulators of paraxial mesoderm specification, MEOX1, a regulator of somite development,
and SOX2, whose repression by TBX6 is necessary for paraxial mesoderm formation. The
observed partition of TBX6 and SOX2 in two separate populations is consistent with other
studies demonstrating the mutual antagonism between these transcription factors. These
results not only confirm the fidelity of this H9 TBX6-mCherry reporter cell line but show a
clear transition from an embryonic gene expression profile to expression characteristics
indicative of paraxial mesoderm differentiation. (n = 3).
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including thiazovivin, a Rho-associated coiled-coil containing protein kinase (ROCK)
inhibitor that blocks actin cytoskeleton reorganization, in the plating media greatly
promoted the survival of Accutase-passaged hESCs and allowed a defined number of
cells to be seeded in each well. Interestingly, this manner of single cell passage seems to
promote a more naïve stem cell state as compared to cells in patches. Additionally,
differentiation appeared to progress in a more uniform manner and a robust increase in
the percentage (88.1%) of TBX6+ cells (Fig.4.4) compared to previous method (~25%,
Fig.4.3). Expression of endogenous TBX6 was 345-fold higher in the reporter-positive
population, while MSGN expression increased to 63-fold, both substantially above the
levels with patch passage. However, the 9-fold increase in MEOX1 expression in the
positive population was half that found at the corresponding time point following patch
passage. This effect is likely because differentiation initiated on single cells has not
progressed to the more mature stage of elevated MEOX1 expression. Furthermore, the
expression of the tailbud and early mesoderm marker FGF8 is reversed, higher in the
TBX6 reporter-negative population in Fig.4.3 but higher in the reporter-positive population
in Fig.4.4. This reinforces the idea that the single cell passage allows for a more
synchronous progression of differentiation, and ultimately greater control of downstream
cell fate.

Identification of cell surface markers that are highly enriched in reporter expressing
cells is an ideal approach for isolating a highly pure population of cells with specific
lineage characteristics. Expression of the chemokine receptor CXCR4 (CD184) was also
25-fold higher in the TBX6+ population (Fig.4.5). Staining for CXCR4 expression on Day
4 indicates a majority (78.3%) of the TBX6+ population is also positive for CXCR4
expression whereas ESC controls and cells not subjected to differentiation factors show
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Figure 4.4. Stem Cell State Affects Differentiation and Reporter Expression.
Passaging as single cells allows for more accurate plating counts and causes a robust
increase in the TBX6+ sorted population. Endogenous TBX6 expression is also much
greater at Day 4, and expression of FGF8 is reversed in the sorted populations compared
to Fig.4.3. Passaging as single cells may promote a more naïve stem cell state as
compared to cells in patches and is a potential cause for the increased expression of
earlier paraxial mesoderm markers and lower expression of the later marker MEOX1, after
the same differentiation duration and conditions as the prior experiment. (n=3).
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no TBX6 reporter expression but are also negative for CXCR4 (Fig.4.5). These results in
CXCR4 gene expression and surface marker presence were found at much lower levels
when assessed following differentiation of patch passaged cells, likely due to the
increased heterogeneity inherent with this method.

4.4. Discussion
In this study, we showed that the inhibition of RAR signaling through the
application of the small molecule inhibitor AGN193109 together with activation of the Wnt
signaling pathway resulted in a robust increase in the formation of paraxial mesoderm
from mouse and human ESCs. Below we discuss our findings within the context of the
published literature on paraxial mesoderm formation.

D

4.4.1 Retinoic acid signaling and paraxial mesoderm
Our studies showed that the inhibition of RAR signaling in conjunction with
activation of the Wnt pathway strongly promoted paraxial mesoderm formation. Tbx6
reporter expression markedly increased in human ESCs when AGN193109 was added
with Wnt3a/CHIR99021 (Fig.4.2). Additionally, gene markers for paraxial mesoderm
formation were also notably up-regulated with RAR inverse agonism (Fig.4.3). However,
treatment with AGN193109, alone, had only a marginal impact on mesoderm induction,
revealing that this drug, in itself, is likely not a direct mesoderm inducer but augments the
ability of Wnt signaling to induce paraxial mesoderm. This suggests that RARs may
inhibit Wnt signaling possibly through direct and/or indirect mechanisms. In support of this
idea, past embryonic studies have shown severe axial truncation occurs in the presence
of excessive levels of retinoic acid79. SurplusCretinoic acid triggers premature
differentiation of posterior cells leading to insufficient trunk expansion due to exhaustion of
the posterior progenitor pool. This caudal progenitor zone exhibits high FGF8 expression
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Figure 4.5. TBX6 Reporter-Positive Cells are Highly Enriched for CXCR4. Staining for
CD184 (CXCR4) expression on Day 4 indicates a majority (78.3%) of the TBX6+ population
(x-axis, mCherry) is also positive for CXCR4 expression (y-axis in bottom panels, APC-A).
ESC controls and cells not subjected to differentiation factors show no TBX6 reporter
expression and are also negative for CXCR4. (n = 2).
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and canonical Wnt signaling through β-catenin to maintain posterior and pre-somitic cell
characteristics. However, in response to retinoic acid, RARs are mobilized and bind to
retinoic acid response elements (RAREs) located upstream of Wnt8a and FGF8 domains
to mediate gene repression61,116. In addition, RA has been shown to induce non-canonical
Wnt signaling that may further antagonize canonical pathway activation leading to loss of
stemness and expression of genes for differentiation117. This may explain why our
treatment with Wnt3a and CHIR99021 was far less efficient in generating paraxial
mesoderm without the addition of AGN193109.

4.4.2. BMP signaling is important for initial mesoderm specification of ESCs
While BMP signaling was not the primary focus of this study, one of the surprising
outcomes, which contrasts with other groups, has to do with the importance of inhibiting
BMP signaling to direct ESCs into paraxial mesoderm. Our studies showed that treatment
with the BMP inhibitor Noggin had no benefit for generating paraxial mesoderm from
mouse ESCs (Fig.3.2) and is actually inhibitory for paraxial mesoderm from human ESCs
(Fig.4.2). In contrast, work by others have shown that inhibition of BMP signaling using
the small molecule inhibitor LDN193189, which targets type I BMP receptors, aids in the
specification of paraxial mesoderm40,41,118. In support of their studies, it is well established
that BMP signaling can redirect the specification of paraxial mesoderm into lateral plate
mesoderm80. However, there is also evidence of an earlier positive role for BMP signaling
in the initial transition of epiblast cells into the primitive streak prior to the specification into
lateral plate mesoderm119. Additionally, BMP signaling has been shown to inhibit Sox2
expression in caudal epiblast cells during their transition into mesoderm28. With this in
mind and unlike mouse ESCs, human ESCs are biologically similar to the epiblast14.
Therefore, it is conceivable that BMP signaling plays a key role in the initial conversion of
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human ESCs out of their fully pluripotent state. Future studies will investigate a possible
earlier role for BMP signaling in paraxial mesoderm formation.

4.4.3. Initial culture conditions may greatly affect differentiation outcomes
Stem cell maintenance and passaging protocols can affect the stem cell state and
lead to variances in the progression of differentiation, even under the same differentiation
culture conditions and duration. It is important to understand how different stem cell
culture techniques can influence the course of a given differentiation protocol. In addition,
identifying surface markers robustly expressed in reporter positive cells will aid in isolating
more homogeneous populations moving forward. Obtaining a uniform population from
this primary differentiation stage may enhance the ability to generate skeletal progenitors
through subsequent differentiation stages.

4.4.4. Conclusion
There is a great interest in understanding how to generate paraxial mesoderm
from ESCs because derivatives of paraxial mesoderm can give rise to a variety of skeletal
cell types including chondrocyte, osteoblast, tenocyte, skeletal muscle, and dermal
fibroblast. Therefore, insights that lead to a breakthrough in the generation of skeletal
precursors from human pluripotent stem cells has considerable therapeutic implications in
terms of cell therapy and/or drug development. Additionally, in vitro models of human
ESC/iPSC differentiation provide a valuable resource for basic research of human
development and disease. In these studies, we highlight the value of RAR as an approach
to increase paraxial mesoderm formation from ESCs. By enhancing the guidance of ESCs
into paraxial mesoderm, downstream efforts to generate different skeletal cell types will be
improved.
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CONCLUSIONS & FUTURE DIRECTIONS

69

CONCLUSIONS & FUTURE DIRECTIONS

Embryonic stem cell technologies are continually advancing research and the
development of treatment strategies for human diseases, including those that impact the
human skeleton. However, a better understanding of how to direct ESCs into mature,
functional skeletal cell types remains a necessity as debate persists regarding the most
appropriate differentiation strategy. Our work has focused on differentiating ESCs along a
multi-stepped embryonic program in order to gain a better understanding of human
skeletal development and ultimately obtain higher quality skeletal progenitor cells for
therapy. This differentiation strategy progresses from ESCs into epiblast and then paraxial
mesoderm, and eventually into sclerotome and mature progenitor cells. The progressive
differentiation of ESCs to simulate their natural maturation during embryonic development
may not be exclusively novel itself, however few studies specifically focus on the axial
skeletal lineage21,22.

We have directed ESCs into paraxial mesoderm through activation of Wnt
signaling along with inverse agonism of the retinoic acid pathway. Additionally, we have
demonstrated the utility of first converting ESCs into epiblast cells prior to mesoderm
induction. This approach is coupled with diagnostic readouts from transgenic reporter cell
lines, including that for Tbx6, a key regulator of paraxial mesoderm specification. Such
stem cell reporter lines allow for real-time visual assessment of the effects of multiple
culture conditions and also permits FACS analysis and sorting of subpopulations without
the need for additional antibody staining. We have shown that key paraxial mesoderm
regulatory genes including Tbx6 and Mesogenin are significantly upregulated in our Tbx6+
reporter positive populations, indicating efficient paraxial mesoderm induction as well as
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reliable reporter function from our differentiation strategy. The ability to isolate a uniform
population from this primary differentiation stage may allow for more effective generation
of subsequent sclerotome populations and ultimately, functional skeletal progenitors for
therapeutic use derived via a differentiation scheme comparable to embryonic
development.

A prevailing interest of our work is to understand how different signaling pathways
regulate the generation of skeletal progenitors. We have focused on the formation of
paraxial mesoderm because it is the source of embryonic tissue that gives rise to bone,
cartilage, muscle and tendon of the axial skeleton. RARs are expressed in epiblast cells
and, during rostral-caudal elongation, in the tailbud of the developing mouse embryo.
Interestingly, this is a region of the embryo lacks RA signaling yet work by others has
indicated that RARγ does have a significant role in regulating the rate of paraxial
mesoderm maturation to properly determine axial length.

Our efforts to differentiate PSCs into paraxial mesoderm have heightened our
interest in the repressor roles of RARs. Our studies have consistently shown that
increasing the repressor function of RARs promotes paraxial mesoderm formation.
However, not until recently have we begun to understand how this happens. Interestingly,
when mouse embryonic stem cells (mESCs) are differentiated into epiblast cells, the
addition of AGN193109 (AGN), an inverse agonist that promotes the repressor function of
RARs, not only results in a more rapid conversion of mESCs into the epiblast state but
promotes the expression of a certain subset of epiblast gene markers with similarity to the
caudal lateral epiblast (CLE), while other epiblast markers are down regulated. During
embryogenesis, maintenance of the CLE is critical for proper axial skeletal elongation15,120.
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Furthermore, continued differentiation of epiblast cells in the presence of AGN results in
the up-regulation of unsegmented paraxial mesoderm marker genes Tbx6 and Msgn1.
However, consistent with the repressor function of RARs, continued AGN treatment
delays further paraxial mesoderm maturation.

Our work using mouse ESCs revealed two distinct developmental roles for RAR
signaling during the very early stages of paraxial mesoderm formation. First, RARs can
influence the differentiation of epiblast cells into a specific kind of epiblast known as the
caudal lateral epiblast (CLE). Preceding mesoderm formation, cells within the mouse
epiblast become further specified into distinct subsets, one of which is the CLE, an
intermediate stem cell population that further differentiates into paraxial mesoderm.
Second, upon the formation of unsegmented or “presomitic” mesoderm, active RAR
signaling promotes its further maturation into segmented or “somitic” mesoderm. Our
studies show that RAR inverse agonist treatment can arrest differentiation at the
presomitic stage, delaying maturation into the somitic phase. Here we propose to further
investigate which RAR subtype(s) are responsible for coordinating these effects at each
stage of differentiation.

We have identified an earlier than appreciated role for RARs in mouse epiblast
cells that is instructive to the formation of paraxial mesoderm. Which RAR(s) mediates this
function will be an active area of investigation for future studies. To address this gap in
knowledge, future work will investigate (1) how individual RARs alter epiblast
differentiation toward the paraxial mesoderm lineage and (2) interrogate directly at the
DNA level how RARs function in a RA independent fashion to regulate gene expression.
Specific RARs will be targeted for genetic disruption using CRISPR methods. The cell
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lines generated will be used for differentiation studies to scrutinize the functionality of
individual small molecules and their effect on specific RARs to mediate cell specification.
Pluripotent stem cells from mouse and human as well as the in vitro culture of mouse
embryos will be used to examine the repressor role of RARs on epiblast differentiation into
paraxial mesoderm. This work will provide a much deeper understanding of how RARs
function independently of RA during early embryonic development. Additionally, this work
will determine at the genetic level how RARs function as transcriptional repressors to
promote paraxial mesoderm formation. In doing so, the field will have a much deeper
understanding of how skeletal progenitors are generated during embryogenesis and from
pluripotent stem cells (PSCs).
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